Veebot Systems has created an image-guided robotic needle-insertion system.
This system takes the guesswork out of one of the world’s most common medical procedures, using patented technology to eliminate painful failed needle sticks and enable healthcare providers to deliver the highest standard of care.
Between blood draws, IV insertions, and vaccine delivery, needle insertions happen more than one billion times a year. Needle insertion represents a fifty-billion-dollar sector within the healthcare industry.
Yet despite its commonality, it’s a difficult task for medical staff. Twenty-five percent of insertion attempts fail, either due to difficult patient anatomy or lack of experience of the person inserting the needle. Failed attempts result in bottlenecks at healthcare facilities and a poor patient experience.
Veebot Systems has created an alternative. Its system uses medical imaging, computer vision, and machine learning to autonomously identify target insertion sites. It then tracks these sites in real-time and robotically aligns a needle for insertion. The result is a less painful experience for patients and more successful one for healthcare workers.
Veebot Systems has been featured in Forbes, Bloomberg, Fast Company, TechCrunch, and FOX News.
The company has received four U.S. patents and one European patent covering its technology. And it has additional patents pending. A working prototype of its system successfully inserted IV needles in a variety of subjects with different body and skin types. Now the company is preparing to conduct a series of clinical trials.